Viemed Healthcare (VMD) EBITDA Margin (2018 - 2026)

Viemed Healthcare has reported EBITDA Margin for 9 years, with the latest figure at 5.7% in Q1 2026.

• For the quarter ending Q1 2026, EBITDA Margin fell 80.0% year-over-year to 5.7%; the trailing twelve-month figure through Mar 2026 stood at 8.17% (down 23.0% YoY), and the FY2025 full-year result was 8.49%, up 347.0% from the prior year.
• EBITDA Margin for Q1 2026 stood at 5.7%, down from 10.99% in the prior quarter.
• The five-year high for EBITDA Margin was 10.99% in Q4 2025, with the low at 3.08% in Q2 2022.
• Historically, EBITDA Margin has averaged 6.46% across 5 years, with a median of 6.35% in 2022.
• Annual changes were most pronounced in 2022 — EBITDA Margin slumped 660 bps — and 2024, when it jumped 379 bps.
• Viemed Healthcare's EBITDA Margin stood at 6.35% in 2022, then rose by 8 bps to 6.85% in 2023, then surged by 55 bps to 10.63% in 2024, then advanced by 3 bps to 10.99% in 2025, then tumbled by 48 bps to 5.7% in 2026.
• The last three EBITDA Margin figures came in at 5.7% (Q1 2026), 10.99% (Q4 2025), and 7.85% (Q3 2025), per Business Quant data.